Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rebecca Claire Hale, M.D., Ph.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Rebecca Hale's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Rebecca Hale has written about over time.
Haploinsufficiency, 1 publications between 2023 and 2023, average publication date March 2023. Suppressor of Cytokine Signaling Proteins, 1 publications between 2023 and 2023, average publication date March 2023. Humans, 3 publications between 2023 and 2023, average publication date July 2023. Adult, 1 publications between 2023 and 2023, average publication date September 2023. Infant, Newborn, 1 publications between 2023 and 2023, average publication date September 2023. Inflammatory Bowel Diseases, 1 publications between 2023 and 2023, average publication date September 2023. Mevalonate Kinase Deficiency, 1 publications between 2023 and 2023, average publication date September 2023. Sweet Syndrome, 1 publications between 2023 and 2023, average publication date September 2023. Antibodies, 1 publications between 2023 and 2023, average publication date September 2023. Glycosylation, 1 publications between 2023 and 2023, average publication date September 2023. Hypersensitivity, 1 publications between 2023 and 2023, average publication date September 2023. Immune System, 1 publications between 2023 and 2023, average publication date September 2023. Polysaccharides, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Hale's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (16)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.